Kathryn Hayashi

Kathryn Hayashi is president and CEO of TRIUMF Innovations.

Canada’s next big bet needs to be on medical isotopes

• Cancer is still the leading cause of death in Canada. Industry is ready to deliver, and with government involvement, we can work together to

Opinion | BY MIKE RENCHECK, MICHAEL CHEGAHNO, KATHRYN HAYASHI, OWEN ROBERTS, DAVE TUCKER | July 27, 2023

Canada’s next big bet needs to be on medical isotopes

Opinion | BY MIKE RENCHECK, MICHAEL CHEGAHNO, KATHRYN HAYASHI, OWEN ROBERTS, DAVE TUCKER | July 27, 2023

• Cancer is still the leading cause of death in Canada. Industry is ready to deliver, and with government involvement, we can work together to

Canada’s next big bet needs to be on medical isotopes

Opinion | BY MIKE RENCHECK, MICHAEL CHEGAHNO, KATHRYN HAYASHI, OWEN ROBERTS, DAVE TUCKER | July 27, 2023

• Cancer is still the leading cause of death in Canada. Industry is ready to deliver, and with government involvement, we can work together to

Canada’s next big bet needs to be on medical isotopes

• Cancer is still the leading cause of death in Canada. Industry is ready to deliver, and with government involvement, we can work together to

Opinion | BY MIKE RENCHECK, MICHAEL CHEGAHNO, KATHRYN HAYASHI, OWEN ROBERTS, DAVE TUCKER | July 27, 2023

Canada’s next big bet needs to be on medical isotopes

Opinion | BY MIKE RENCHECK, MICHAEL CHEGAHNO, KATHRYN HAYASHI, OWEN ROBERTS, DAVE TUCKER | July 27, 2023

• Cancer is still the leading cause of death in Canada. Industry is ready to deliver, and with government involvement, we can work together to

Canada’s next big bet needs to be on medical isotopes

Opinion | BY MIKE RENCHECK, MICHAEL CHEGAHNO, KATHRYN HAYASHI, OWEN ROBERTS, DAVE TUCKER | July 27, 2023

• Cancer is still the leading cause of death in Canada. Industry is ready to deliver, and with government involvement, we can work together to

More Stories